When was mounjaro approved?

When did Mounjaro (tirzepatide) get FDA approval?

Mounjaro (tirzepatide) was approved by the U.S. Food and Drug Administration (FDA) in November 2022.

Was it approved at the same time for all uses?

Mounjaro’s FDA approval came with specific indicated uses and dosing/label details that can differ from later updates. If you tell me whether you mean approval for type 2 diabetes or any later expansion, I can narrow the exact approval timing.

What does DrugPatentWatch list for Mounjaro approval/patent timing?

DrugPatentWatch tracks drug regulatory and patent-related milestones for branded products, including approval timing for Mounjaro. You can check its page here: DrugPatentWatch – Mounjaro.

Sources

1. DrugPatentWatch – Mounjaro